1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Melanoma Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chemotherapy 1.2.3 Immunotherapy 1.2.4 Targeted Therapy 1.3 Market by Application 1.3.1 Global Melanoma Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Melanoma Drugs Market Perspective (2016-2027) 2.2 Melanoma Drugs Growth Trends by Regions 2.2.1 Melanoma Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Melanoma Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Melanoma Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Melanoma Drugs Industry Dynamic 2.3.1 Melanoma Drugs Market Trends 2.3.2 Melanoma Drugs Market Drivers 2.3.3 Melanoma Drugs Market Challenges 2.3.4 Melanoma Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Melanoma Drugs Players by Revenue 3.1.1 Global Top Melanoma Drugs Players by Revenue (2016-2021) 3.1.2 Global Melanoma Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Melanoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Melanoma Drugs Revenue 3.4 Global Melanoma Drugs Market Concentration Ratio 3.4.1 Global Melanoma Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Melanoma Drugs Revenue in 2020 3.5 Melanoma Drugs Key Players Head office and Area Served 3.6 Key Players Melanoma Drugs Product Solution and Service 3.7 Date of Enter into Melanoma Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Melanoma Drugs Breakdown Data by Type 4.1 Global Melanoma Drugs Historic Market Size by Type (2016-2021) 4.2 Global Melanoma Drugs Forecasted Market Size by Type (2022-2027) 5 Melanoma Drugs Breakdown Data by Application 5.1 Global Melanoma Drugs Historic Market Size by Application (2016-2021) 5.2 Global Melanoma Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Melanoma Drugs Market Size (2016-2027) 6.2 North America Melanoma Drugs Market Size by Type 6.2.1 North America Melanoma Drugs Market Size by Type (2016-2021) 6.2.2 North America Melanoma Drugs Market Size by Type (2022-2027) 6.2.3 North America Melanoma Drugs Market Size by Type (2016-2027) 6.3 North America Melanoma Drugs Market Size by Application 6.3.1 North America Melanoma Drugs Market Size by Application (2016-2021) 6.3.2 North America Melanoma Drugs Market Size by Application (2022-2027) 6.3.3 North America Melanoma Drugs Market Size by Application (2016-2027) 6.4 North America Melanoma Drugs Market Size by Country 6.4.1 North America Melanoma Drugs Market Size by Country (2016-2021) 6.4.2 North America Melanoma Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Melanoma Drugs Market Size (2016-2027) 7.2 Europe Melanoma Drugs Market Size by Type 7.2.1 Europe Melanoma Drugs Market Size by Type (2016-2021) 7.2.2 Europe Melanoma Drugs Market Size by Type (2022-2027) 7.2.3 Europe Melanoma Drugs Market Size by Type (2016-2027) 7.3 Europe Melanoma Drugs Market Size by Application 7.3.1 Europe Melanoma Drugs Market Size by Application (2016-2021) 7.3.2 Europe Melanoma Drugs Market Size by Application (2022-2027) 7.3.3 Europe Melanoma Drugs Market Size by Application (2016-2027) 7.4 Europe Melanoma Drugs Market Size by Country 7.4.1 Europe Melanoma Drugs Market Size by Country (2016-2021) 7.4.2 Europe Melanoma Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Melanoma Drugs Market Size (2016-2027) 8.2 Asia-Pacific Melanoma Drugs Market Size by Type 8.2.1 Asia-Pacific Melanoma Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Melanoma Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Melanoma Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Melanoma Drugs Market Size by Application 8.3.1 Asia-Pacific Melanoma Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Melanoma Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Melanoma Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Melanoma Drugs Market Size by Region 8.4.1 Asia-Pacific Melanoma Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Melanoma Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Melanoma Drugs Market Size (2016-2027) 9.2 Latin America Melanoma Drugs Market Size by Type 9.2.1 Latin America Melanoma Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Melanoma Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Melanoma Drugs Market Size by Type (2016-2027) 9.3 Latin America Melanoma Drugs Market Size by Application 9.3.1 Latin America Melanoma Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Melanoma Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Melanoma Drugs Market Size by Application (2016-2027) 9.4 Latin America Melanoma Drugs Market Size by Country 9.4.1 Latin America Melanoma Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Melanoma Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Melanoma Drugs Market Size (2016-2027) 10.2 Middle East & Africa Melanoma Drugs Market Size by Type 10.2.1 Middle East & Africa Melanoma Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Melanoma Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Melanoma Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Melanoma Drugs Market Size by Application 10.3.1 Middle East & Africa Melanoma Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Melanoma Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Melanoma Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Melanoma Drugs Market Size by Country 10.4.1 Middle East & Africa Melanoma Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Melanoma Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Details 11.1.2 Amgen Business Overview 11.1.3 Amgen Melanoma Drugs Introduction 11.1.4 Amgen Revenue in Melanoma Drugs Business (2016-2021) 11.1.5 Amgen Recent Development 11.2 Bristol-Myers Squibb 11.2.1 Bristol-Myers Squibb Company Details 11.2.2 Bristol-Myers Squibb Business Overview 11.2.3 Bristol-Myers Squibb Melanoma Drugs Introduction 11.2.4 Bristol-Myers Squibb Revenue in Melanoma Drugs Business (2016-2021) 11.2.5 Bristol-Myers Squibb Recent Development 11.3 Roche 11.3.1 Roche Company Details 11.3.2 Roche Business Overview 11.3.3 Roche Melanoma Drugs Introduction 11.3.4 Roche Revenue in Melanoma Drugs Business (2016-2021) 11.3.5 Roche Recent Development 11.4 Genentech 11.4.1 Genentech Company Details 11.4.2 Genentech Business Overview 11.4.3 Genentech Melanoma Drugs Introduction 11.4.4 Genentech Revenue in Melanoma Drugs Business (2016-2021) 11.4.5 Genentech Recent Development 11.5 Janssen Biotech 11.5.1 Janssen Biotech Company Details 11.5.2 Janssen Biotech Business Overview 11.5.3 Janssen Biotech Melanoma Drugs Introduction 11.5.4 Janssen Biotech Revenue in Melanoma Drugs Business (2016-2021) 11.5.5 Janssen Biotech Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Melanoma Drugs Introduction 11.6.4 Novartis Revenue in Melanoma Drugs Business (2016-2021) 11.6.5 Novartis Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Melanoma Drugs Introduction 11.7.4 Pfizer Revenue in Melanoma Drugs Business (2016-2021) 11.7.5 Pfizer Recent Development 11.8 Sanofi 11.8.1 Sanofi Company Details 11.8.2 Sanofi Business Overview 11.8.3 Sanofi Melanoma Drugs Introduction 11.8.4 Sanofi Revenue in Melanoma Drugs Business (2016-2021) 11.8.5 Sanofi Recent Development 11.9 Takeda Pharma 11.9.1 Takeda Pharma Company Details 11.9.2 Takeda Pharma Business Overview 11.9.3 Takeda Pharma Melanoma Drugs Introduction 11.9.4 Takeda Pharma Revenue in Melanoma Drugs Business (2016-2021) 11.9.5 Takeda Pharma Recent Development 11.10 Teva Pharma 11.10.1 Teva Pharma Company Details 11.10.2 Teva Pharma Business Overview 11.10.3 Teva Pharma Melanoma Drugs Introduction 11.10.4 Teva Pharma Revenue in Melanoma Drugs Business (2016-2021) 11.10.5 Teva Pharma Recent Development 11.11 Merck Group 11.11.1 Merck Group Company Details 11.11.2 Merck Group Business Overview 11.11.3 Merck Group Melanoma Drugs Introduction 11.11.4 Merck Group Revenue in Melanoma Drugs Business (2016-2021) 11.11.5 Merck Group Recent Development 11.12 Shanghai Junshi Biosciences Co.,Ltd 11.12.1 Shanghai Junshi Biosciences Co.,Ltd Company Details 11.12.2 Shanghai Junshi Biosciences Co.,Ltd Business Overview 11.12.3 Shanghai Junshi Biosciences Co.,Ltd Melanoma Drugs Introduction 11.12.4 Shanghai Junshi Biosciences Co.,Ltd Revenue in Melanoma Drugs Business (2016-2021) 11.12.5 Shanghai Junshi Biosciences Co.,Ltd Recent Development 11.13 Innovent Biologics 11.13.1 Innovent Biologics Company Details 11.13.2 Innovent Biologics Business Overview 11.13.3 Innovent Biologics Melanoma Drugs Introduction 11.13.4 Innovent Biologics Revenue in Melanoma Drugs Business (2016-2021) 11.13.5 Innovent Biologics Recent Development 11.14 Jiangsu Hengrui Medicine Co.,Ltd. 11.14.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Details 11.14.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview 11.14.3 Jiangsu Hengrui Medicine Co.,Ltd. Melanoma Drugs Introduction 11.14.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Melanoma Drugs Business (2016-2021) 11.14.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development 11.15 BeiGene, Ltd. 11.15.1 BeiGene, Ltd. Company Details 11.15.2 BeiGene, Ltd. Business Overview 11.15.3 BeiGene, Ltd. Melanoma Drugs Introduction 11.15.4 BeiGene, Ltd. Revenue in Melanoma Drugs Business (2016-2021) 11.15.5 BeiGene, Ltd. Recent Development 11.16 Grand Pharmaceutical (China) Co., Ltd 11.16.1 Grand Pharmaceutical (China) Co., Ltd Company Details 11.16.2 Grand Pharmaceutical (China) Co., Ltd Business Overview 11.16.3 Grand Pharmaceutical (China) Co., Ltd Melanoma Drugs Introduction 11.16.4 Grand Pharmaceutical (China) Co., Ltd Revenue in Melanoma Drugs Business (2016-2021) 11.16.5 Grand Pharmaceutical (China) Co., Ltd Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Melanoma Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chemotherapy Table 3. Key Players of Immunotherapy Table 4. Key Players of Targeted Therapy Table 5. Global Melanoma Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Melanoma Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Melanoma Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Melanoma Drugs Market Share by Regions (2016-2021) Table 9. Global Melanoma Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Melanoma Drugs Market Share by Regions (2022-2027) Table 11. Melanoma Drugs Market Trends Table 12. Melanoma Drugs Market Drivers Table 13. Melanoma Drugs Market Challenges Table 14. Melanoma Drugs Market Restraints Table 15. Global Melanoma Drugs Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Melanoma Drugs Market Share by Players (2016-2021) Table 17. Global Top Melanoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Drugs as of 2020) Table 18. Ranking of Global Top Melanoma Drugs Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Melanoma Drugs Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Melanoma Drugs Product Solution and Service Table 22. Date of Enter into Melanoma Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Melanoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 25. Global Melanoma Drugs Revenue Market Share by Type (2016-2021) Table 26. Global Melanoma Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Melanoma Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Melanoma Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Melanoma Drugs Revenue Market Share by Application (2016-2021) Table 30. Global Melanoma Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Melanoma Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Melanoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 33. North America Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Melanoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 35. North America Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Melanoma Drugs Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Melanoma Drugs Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Melanoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Melanoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Melanoma Drugs Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Melanoma Drugs Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Melanoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Melanoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Melanoma Drugs Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Melanoma Drugs Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Melanoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Melanoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Melanoma Drugs Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Melanoma Drugs Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Melanoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Melanoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Melanoma Drugs Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Melanoma Drugs Market Size by Country (2022-2027) & (US$ Million) Table 62. Amgen Company Details Table 63. Amgen Business Overview Table 64. Amgen Melanoma Drugs Product Table 65. Amgen Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 66. Amgen Recent Development Table 67. Bristol-Myers Squibb Company Details Table 68. Bristol-Myers Squibb Business Overview Table 69. Bristol-Myers Squibb Melanoma Drugs Product Table 70. Bristol-Myers Squibb Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 71. Bristol-Myers Squibb Recent Development Table 72. Roche Company Details Table 73. Roche Business Overview Table 74. Roche Melanoma Drugs Product Table 75. Roche Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 76. Roche Recent Development Table 77. Genentech Company Details Table 78. Genentech Business Overview Table 79. Genentech Melanoma Drugs Product Table 80. Genentech Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 81. Genentech Recent Development Table 82. Janssen Biotech Company Details Table 83. Janssen Biotech Business Overview Table 84. Janssen Biotech Melanoma Drugs Product Table 85. Janssen Biotech Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 86. Janssen Biotech Recent Development Table 87. Novartis Company Details Table 88. Novartis Business Overview Table 89. Novartis Melanoma Drugs Product Table 90. Novartis Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 91. Novartis Recent Development Table 92. Pfizer Company Details Table 93. Pfizer Business Overview Table 94. Pfizer Melanoma Drugs Product Table 95. Pfizer Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 96. Pfizer Recent Development Table 97. Sanofi Company Details Table 98. Sanofi Business Overview Table 99. Sanofi Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 100. Sanofi Recent Development Table 101. Takeda Pharma Company Details Table 102. Takeda Pharma Business Overview Table 103. Takeda Pharma Melanoma Drugs Product Table 104. Takeda Pharma Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 105. Takeda Pharma Recent Development Table 106. Teva Pharma Company Details Table 107. Teva Pharma Business Overview Table 108. Teva Pharma Melanoma Drugs Product Table 109. Teva Pharma Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 110. Teva Pharma Recent Development Table 111. Merck Group Company Details Table 112. Merck Group Business Overview Table 113. Merck Group Melanoma Drugs Product Table 114. Merck Group Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 115. Merck Group Recent Development Table 116. Shanghai Junshi Biosciences Co.,Ltd Company Details Table 117. Shanghai Junshi Biosciences Co.,Ltd Business Overview Table 118. Shanghai Junshi Biosciences Co.,Ltd Melanoma Drugs Product Table 119. Shanghai Junshi Biosciences Co.,Ltd Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 120. Shanghai Junshi Biosciences Co.,Ltd Recent Development Table 121. Innovent Biologics Company Details Table 122. Innovent Biologics Business Overview Table 123. Innovent Biologics Melanoma Drugs Product Table 124. Innovent Biologics Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 125. Innovent Biologics Recent Development Table 126. Jiangsu Hengrui Medicine Co.,Ltd. Company Details Table 127. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview Table 128. Jiangsu Hengrui Medicine Co.,Ltd. Melanoma Drugs Product Table 129. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 130. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development Table 131. BeiGene, Ltd. Company Details Table 132. BeiGene, Ltd. Business Overview Table 133. BeiGene, Ltd. Melanoma Drugs Product Table 134. BeiGene, Ltd. Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 135. BeiGene, Ltd. Recent Development Table 136. Grand Pharmaceutical (China) Co., Ltd Company Details Table 137. Grand Pharmaceutical (China) Co., Ltd Business Overview Table 138. Grand Pharmaceutical (China) Co., Ltd Melanoma Drugs Product Table 139. Grand Pharmaceutical (China) Co., Ltd Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million) Table 140. Grand Pharmaceutical (China) Co., Ltd Recent Development Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Global Melanoma Drugs Market Share by Type: 2020 VS 2027 Figure 2. Chemotherapy Features Figure 3. Immunotherapy Features Figure 4. Targeted Therapy Features Figure 5. Global Melanoma Drugs Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Others Case Studies Figure 9. Melanoma Drugs Report Years Considered Figure 10. Global Melanoma Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Melanoma Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Melanoma Drugs Market Share by Regions: 2020 VS 2027 Figure 13. Global Melanoma Drugs Market Share by Regions (2022-2027) Figure 14. Global Melanoma Drugs Market Share by Players in 2020 Figure 15. Global Top Melanoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Drugs as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Melanoma Drugs Revenue in 2020 Figure 17. Global Melanoma Drugs Revenue Market Share by Type (2016-2021) Figure 18. Global Melanoma Drugs Revenue Market Share by Type (2022-2027) Figure 19. North America Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Melanoma Drugs Market Share by Type (2016-2027) Figure 21. North America Melanoma Drugs Market Share by Application (2016-2027) Figure 22. North America Melanoma Drugs Market Share by Country (2016-2027) Figure 23. United States Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Melanoma Drugs Market Share by Type (2016-2027) Figure 27. Europe Melanoma Drugs Market Share by Application (2016-2027) Figure 28. Europe Melanoma Drugs Market Share by Country (2016-2027) Figure 29. Germany Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Melanoma Drugs Market Share by Type (2016-2027) Figure 37. Asia-Pacific Melanoma Drugs Market Share by Application (2016-2027) Figure 38. Asia-Pacific Melanoma Drugs Market Share by Region (2016-2027) Figure 39. China Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Melanoma Drugs Market Share by Type (2016-2027) Figure 47. Latin America Melanoma Drugs Market Share by Application (2016-2027) Figure 48. Latin America Melanoma Drugs Market Share by Country (2016-2027) Figure 49. Mexico Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Melanoma Drugs Market Share by Type (2016-2027) Figure 53. Middle East & Africa Melanoma Drugs Market Share by Application (2016-2027) Figure 54. Middle East & Africa Melanoma Drugs Market Share by Country (2016-2027) Figure 55. Turkey Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Amgen Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 60. Roche Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 61. Genentech Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 62. Janssen Biotech Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 63. Novartis Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 64. Pfizer Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 65. Sanofi Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 66. Takeda Pharma Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 67. Teva Pharma Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 68. Merck Group Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 69. Shanghai Junshi Biosciences Co.,Ltd Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 70. Innovent Biologics Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 71. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 72. BeiGene, Ltd. Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 73. Grand Pharmaceutical (China) Co., Ltd Revenue Growth Rate in Melanoma Drugs Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Amgen Bristol-Myers Squibb Roche Genentech Janssen Biotech Novartis Pfizer Sanofi Takeda Pharma Teva Pharma Merck Group Shanghai Junshi Biosciences Co.,Ltd Innovent Biologics Jiangsu Hengrui Medicine Co.,Ltd. BeiGene, Ltd. Grand Pharmaceutical (China) Co., Ltd